Fluoroquinolones, the Cornerstone of Treatment of Drug-Resistant Tuberculosis: A Pharmacokinetic and Pharmacodynamic Approach

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|27|2900-2930

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.27, 2011-09, pp. : 2900-2930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ensure a comprehensive approach when treating drug-resistant tuberculosis

By  

Drugs & Therapy Perspectives, Vol. 28, Iss. 3, 2012-03 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

Drug-Resistant Tuberculosis: What are the Treatment Options?

By Albanna Amr S.   Menzies Dick  

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Fluoroquinolones for the Treatment of Pulmonary Tuberculosis

By Moadebi Susanne  

Drugs, Vol. 67, Iss. 14, 2007-01 ,pp. : 2077-2099

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Factors in the Modern Drug Treatment of Tuberculosis

By Graham Douglas J.   McLeod M-J.  

Clinical Pharmacokinetics, Vol. 37, Iss. 2, 1999-08 ,pp. : 127-146

Adis International

Access to resources Recommend Favorite

Pediatric Drug-Resistant Tuberculosis: A Global Perspective

By Reubenson Gary  

Pediatric Drugs, Vol. 13, Iss. 6, 2011-12 ,pp. : 349-355

Adis International

Access to resources Recommend Favorite